Structure, function and modulation of retinoic acid receptor beta, a tumor suppressor

Area of Science:

• Molecular Biology
• Cancer Research
• Pharmacology

Background:

• Retinoic acid receptor beta (RARbeta) is frequently deleted or silenced in early tumor progression, suggesting a tumor suppressor role.
• Understanding RARbeta's molecular mechanisms is crucial for cancer therapy.
• Recent advances offer new tools for RARbeta analysis and therapeutic targeting.

Purpose of the Study:

• To elucidate the structure, function, and transcriptional mechanisms of RARbeta.
• To explore the therapeutic potential of RARbeta modulators.
• To understand the selectivity of RARbeta ligands through rational drug design.

Main Methods:

• Crystal structure elucidation of the ligand-binding domain.
• Discovery and use of selective and isoform-selective agonists.
• Investigation of RARbeta's role in retinoic acid-induced apoptosis via TRAIL.

Main Results:

• The crystal structure of the agonist-bound RARbeta ligand-binding domain has been determined.
• Selective agonists, including isoform-specific ligands, have been identified for in vivo studies.
• RARbeta mediates a tumor-specific apoptosis program involving TRAIL.

Conclusions:

• RARbeta's tumor suppressive function is linked to its structure and ligand-dependent activity.
• Selective agonists and structural insights facilitate the study and potential exploitation of RARbeta.
• RARbeta plays a key role in retinoic acid-induced apoptosis, offering therapeutic avenues.